Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 3 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
The Role of Membrane-Associated E3 Ubiquitin Ligases in Cancer.
Front Pharmacol. 2022 Jul 1;13:928794. doi: 10.3389/fphar.2022.928794. eCollection 2022.
Front Pharmacol. 2022.
PMID: 35847032
Free PMC article.
Review.
Structure-based rational design enables efficient discovery of a new selective and potent AKT PROTAC degrader.
Zhu CL, Luo X, Tian T, Rao Z, Wang H, Zhou Z, Mi T, Chen D, Xu Y, Wu Y, Che J, Zhou Y, Li J, Dong X.
Zhu CL, et al. Among authors: zhou z.
Eur J Med Chem. 2022 Aug 5;238:114459. doi: 10.1016/j.ejmech.2022.114459. Epub 2022 May 19.
Eur J Med Chem. 2022.
PMID: 35635954
Item in Clipboard
Noncovalent CDK12/13 dual inhibitors-based PROTACs degrade CDK12-Cyclin K complex and induce synthetic lethality with PARP inhibitor.
Niu T, Li K, Jiang L, Zhou Z, Hong J, Chen X, Dong X, He Q, Cao J, Yang B, Zhu CL.
Niu T, et al. Among authors: zhou z.
Eur J Med Chem. 2022 Jan 15;228:114012. doi: 10.1016/j.ejmech.2021.114012. Epub 2021 Nov 25.
Eur J Med Chem. 2022.
PMID: 34864331
Item in Clipboard
Cite
Cite